Marks Group Wealth Management’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Marks Group Wealth Management’s Portfolio TMDI Stock Details TMDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,555	Closed	-$6.97K	–	297
2022 Q4	$6.97K	Hold	10,555	–	–	﹤0.01%	276
2022 Q3	$5K	Hold	10,555	–	–	﹤0.01%	269
2022 Q2	$5K	Hold	10,555	–	–	﹤0.01%	287
2022 Q1	$6K	Hold	10,555	–	–	﹤0.01%	304
2021 Q4	$7K	Buy	+10,555	New	+$11.9K	﹤0.01%	311
2021 Q3	–	Sell	-10,555	Closed	-$18K	–	301
2021 Q2	$18K	Hold	10,555	–	–	﹤0.01%	269
2021 Q1	$18K	Hold	10,555	–	–	﹤0.01%	254
2020 Q4	$18K	Hold	10,555	–	–	﹤0.01%	255
2020 Q3	$8K	Hold	10,555	–	–	﹤0.01%	245
2020 Q2	$9K	Buy	+10,555	New	+$5.41K	﹤0.01%	238

Other funds holding TMDI

Essex LLC Deer Park, Illinois $659M AUM 41.98% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

Waterford Advisors Orchard Park, New York $315M AUM 15.21% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

MCA

Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return

DIS

Diversified Investment Strategies Baton Rouge, Louisiana $157M AUM 24.09% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Marks Group Wealth Management's TMDI Position: Q1 2023 in Review

Marks Group Wealth Management sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 10,555 shares — an estimated $6.97K sold.

Marks Group Wealth Management first reported a position in TMDI in Q2 2020 and held it in 10 quarters. The position peaked at $18K in Q2 2021. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

Marks Group Wealth Management reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Marks Group Wealth Management sold 10,555 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $6.97K.
Marks Group Wealth Management first reported a position in Titan Medical Inc. Ordinary Shares in Q2 2020 and held it in 10 quarters.
Marks Group Wealth Management's Titan Medical Inc. Ordinary Shares position peaked at $18K in Q2 2021.
12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on Marks Group Wealth Management's 13F filing for Q1 2023, filed 3 May 2023.